Arcus Biosciences, Inc. (RCUS) Profit Margin
Arcus Biosciences, Inc. (RCUS) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2018-12-31 | -593.73% |
| 2019-12-31 | -564.73% |
| 2020-12-31 | -158.49% |
| 2021-12-31 | 13.84% |
| 2022-12-31 | -238.39% |
| 2023-12-31 | -262.39% |
| 2024-12-31 | -109.69% |
| 2025-12-31 | -142.91% |
How RCUS compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | -85.44% |
| VNDA | Vanda Pharmaceuticals Inc. | -102.02% |
| ENTA | Enanta Pharmaceuticals Inc. | -125.36% |
| SNDX | Syndax Pharmaceuticals Inc. | -165.60% |
| AQST | Aquestive Therapeutics Inc. | -188.09% |
These are five companies in the same sector as RCUS with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Arcus Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("RCUS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RCUS | $29.71 | +1.47% | 1.53M |
| 3 | ||||
| 4 | ||||
| 5 |